1. Home
  2. UUUU vs PRAX Comparison

UUUU vs PRAX Comparison

Compare UUUU & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Fuels Inc (Canada)

UUUU

Energy Fuels Inc (Canada)

HOLD

Current Price

$22.08

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$329.15

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UUUU
PRAX
Founded
1987
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
9.6B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
UUUU
PRAX
Price
$22.08
$329.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
15
Target Price
$19.92
$572.13
AVG Volume (30 Days)
10.2M
364.5K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,922,000.00
N/A
Revenue This Year
$70.84
N/A
Revenue Next Year
$51.17
$6,395.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$26.70
52 Week High
$27.90
$354.87

Technical Indicators

Market Signals
Indicator
UUUU
PRAX
Relative Strength Index (RSI) 51.15 53.36
Support Level $19.34 $290.36
Resistance Level $23.61 N/A
Average True Range (ATR) 1.78 18.31
MACD -0.11 -2.58
Stochastic Oscillator 63.68 56.70

Price Performance

Historical Comparison
UUUU
PRAX

About UUUU Energy Fuels Inc (Canada)

Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: